The Butterfly Foundation is encouraging clinicians to refer their waitlisted patients to 'In the Wings', a free single-session intervention service.
It used to be a familiar scene for Emergency Department Director Prof. Paul Preisz. A psychiatric or drug-affected patient being ferried to and from departments.
Based on levels of a specific protein found in the brain, the test is reported to be the first of its kind in the world.
QIMR Berghofer Medical Research Institute is calling for south-east Queenslanders diagnosed with obsessive-compulsive disorder to join a clinical trial of a new brain stimulation treatment.
The active compound in magic mushrooms — psilocybin — has been found to produce large, rapid and sustained improvements in patients with treatment-resistant major depressive disorder.
A new study shows female university students are saving their calories for binge drinking.
Lifeline has launched a purpose-built helpline to support those affected by the recent Australian bushfire crisis.
A US research team has developed a computer that can accurately predict whether an antidepressant will work, based on patients' brain activity.
UK and US researchers have found that the 'rubber hand illusion' could help those with obsessive compulsive disorder (OCD) overcome their condition without the stress caused by exposure therapy.
The repeal of MEDEVAC could impact the long-term physical and mental health of asylum seekers held in offshore processing at Nauru and Manus Island, warns the Chair of the RACGP Refugee Health Specific Interests Network, Dr Kate Walker.
Australians with complex eating disorders such as anorexia nervosa and bulimia will be able to access new services through Medicare from 1 November 2019.
A Swedish observational study has found that PTSD and other stress-related disorders are associated with a subsequent risk of life-threatening infections such as meningitis and sepsis.
Researchers have found that a medium dose of methylphenidate (MPH) has the strongest beneficial effects on inhibitory control in children with ADHD.
New Australian research has found that a significant number of sleep apnoea patients are depressed, with a quarter on antidepressants.
A new study has found that the overproduction of kynurenic acid in schizophrenia patients could be detrimental to brain function.